These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1541067)

  • 21. Angiotensin converting enzyme inhibitor and chronic renal failure.
    Sitprija V; Lumlertgul D
    J Med Assoc Thai; 1993 Jul; 76(7):359-67. PubMed ID: 8089635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P; Perna A; Mosconi L; Matalone M; Pisoni R; Gaspari F; Remuzzi G
    Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].
    Duclos J
    Rev Med Chil; 1993 Mar; 121(3):286-91. PubMed ID: 8248641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ACE inhibitors' effect on kidney function].
    Grönhagen-Riska C
    Nord Med; 1990; 105(8-9):219-22. PubMed ID: 2216687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ACE inhibitors and the kidney].
    Hörl WH
    Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelets, antiplatelet therapy, and diabetic nephropathy.
    Nath KA
    Mayo Clin Proc; 1988 Jan; 63(1):80-5. PubMed ID: 3275846
    [No Abstract]   [Full Text] [Related]  

  • 29. Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone?
    Hoover PL; Mold JW
    J Okla State Med Assoc; 2008 May; 101(5):80-2. PubMed ID: 18678202
    [No Abstract]   [Full Text] [Related]  

  • 30. Dipyridamole plus aspirin in cerebrovascular disease.
    Cohen SN
    Arch Neurol; 2000 Jul; 57(7):1086-7. PubMed ID: 10892000
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of fish oils on plasma lipid levels in hyperlipidemics].
    Skorepa J; Hrabák P; Zák A; Zeman M; Sindelková E
    Cas Lek Cesk; 1985 Aug; 124(31):970-3. PubMed ID: 3896497
    [No Abstract]   [Full Text] [Related]  

  • 32. Does coconut oil improve cholesterol by raising good cholesterol, or should I use fish oil?
    Mayo Clin Health Lett; 2012 Aug; 30(8):8. PubMed ID: 23045741
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.
    Hogg RJ; Fitzgibbons L; Atkins C; Nardelli N; Bay RC;
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1167-72. PubMed ID: 17699343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis and MaxEPA.
    Cendrowski W
    Br J Clin Pract; 1986 Sep; 40(9):365-7. PubMed ID: 3542002
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention and treatment of diabetic nephropathy.
    Wittmann I; Molnár GA; Degrell P; Wagner Z; Tamaskó M; Laczy B; Brasnyó P; Wagner L; Nagy J
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S36-42. PubMed ID: 15955373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary stroke prevention and antiplatelet therapy.
    Horton HL
    J Am Coll Cardiol; 2006 Jun; 47(12):2568; author reply 2569-70. PubMed ID: 16781394
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of 'MaxEPA' in the treatment of patients with Behçet's disease.
    Kürkçüoğlu N; Tandoğdu R
    Br J Dermatol; 1989 Nov; 121(5):667-8. PubMed ID: 2597640
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients.
    Donnelly SM; Ali MA; Churchill DN
    J Am Soc Nephrol; 1992 May; 2(11):1634-9. PubMed ID: 1610984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis.
    Cheng IK; Chan PC; Chan MK
    Nephrol Dial Transplant; 1990; 5(4):241-6. PubMed ID: 2113220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acetylsalicylic acid of fish oil for the prevention of degenerative circulatory diseases?].
    Wehmeier A; Schneider W
    Dtsch Med Wochenschr; 1990 Jan; 115(1):30-5. PubMed ID: 2403912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.